Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-1322

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-1322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Atorvastatin Calcium 40mg 70518 1322 01)

Label for Atorvastatin Calcium 40 mg film-coated tablets, quantity 90, labeled as RX only. The label includes the NDC 70518-1322-01, repackaged by RemedyRepack Inc., with manufacturer information Apotex Corp., Weston, FL. Directions refer to the package insert, and storage conditions are specified.*

FDA Label Image

Mm3 (Atorvastatin Calcium 40mg 70518 1322 02)

Label for Atorvastatin Calcium 40 mg film-coated tablets. The package contains 30 tablets. The label includes the NDC 70518-1322-02, indicates prescription use only, and lists RemedyRepack Inc. as the repackager. Manufacturer is Apotex Corp., Weston, FL. Storage instructions and a QR code are also visible.*

FDA Label Image

Atorvastatin Calcium 40mg 70518 1322 04

Label for Atorvastatin Calcium 40 mg film-coated tablets, quantity 28, manufactured by Apotex Corp., packaged by RemedyRepack Inc. The label includes prescription information, NDC 70518-1322-04, storage temperatures, and a caution to keep medication out of children's reach. Barcodes and a QR code are also present.*

FDA Label Image

Figure 01

A line graph showing cumulative incidence (%) over time in years, comparing Atorvastatin and Placebo groups. The chart plots incidence rates on the vertical axis and duration up to 3.5 years on the horizontal axis, illustrating lower incidence for Atorvastatin compared to Placebo with hazard ratio and p-value noted.*

FDA Label Image

Figure 02

A line graph displaying cumulative hazard percentage over time in years, comparing Atorvastatin and placebo groups. The x-axis shows time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard (%). The Atorvastatin group shows a lower cumulative hazard than placebo, with hazard ratio (HR) 0.63 (0.48-0.83), p=0.001.*

FDA Label Image

Figure 03

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over five years, with curves for Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.